Chemokines

Experimental Therapeutics
Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia
C. M. Salvatore, C. Techasaensiri, C. Tagliabue, K. Katz, N. Leos, A. M. Gomez, G. H. McCracken, R. D. Hardy
Biologic Response Modifiers
Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines
Teresa Krakauer, Marilyn Buckley
Antiviral Agents
Activation by 9-(R)-[2-(Phosphonomethoxy)Propyl]Adenine of Chemokine (RANTES, Macrophage Inflammatory Protein 1α) and Cytokine (Tumor Necrosis Factor Alpha, Interleukin-10 [IL-10], IL-1β) Production
Zdenĕk Zı́dek, Daniela Franková, Antonı́n Holý
Biologic Response Modifiers
Antibiotic-Induced Cell Wall Fragments ofStaphylococcus aureus Increase Endothelial Chemokine Secretion and Adhesiveness for Granulocytes
P. van Langevelde, E. Ravensbergen, P. Grashoff, H. Beekhuizen, P. H. P. Groeneveld, J. T. van Dissel
Mechanisms of Resistance
Plasmid-Mediated Resistance to Thrombin-Induced Platelet Microbicidal Protein in Staphylococci: Role of theqacA Locus
Leon Iri Kupferwasser, Ronald A. Skurray, Melissa H. Brown, Neville Firth, Michael R. Yeaman, Arnold S. Bayer
Mechanisms of Action: Physiological Effects
In Vitro Antibacterial Activities of Platelet Microbicidal Protein and Neutrophil Defensin against Staphylococcus aureus Are Influenced by Antibiotics Differing in Mechanism of Action
Yan-Qiong Xiong, Michael R. Yeaman, Arnold S. Bayer
Mechanisms of Resistance
In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein among Clinical Bacteremic Isolates of Staphylococcus aureus Correlates with an Endovascular Infectious Source
Arnold S. Bayer, Darwin Cheng, Michael R. Yeaman, G. Ralph Corey, R. Scott McClelland, Lizzie J. Harrel, Vance G. Fowler